Literature DB >> 21438841

Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation.

Wei Li1, Shu-Lan Zhang, Ning Wang, Bin-Bin Zhang, Ming Li.   

Abstract

Regulation of Ca(2+) channels has been implicated in the progression of tumor cells. We report here that T-type Ca(2+) channel expression in human ovarian cancer tissues is greatly increased compared to normal ovarian tissues. Blockade of T-type Ca(2+) channel with NNC 55-0396, mibefradil, or by specifically knocking down the expression of these proteins with siRNA-Ca(v)3.1/3.2 suppressed the proliferation of two ovarian cancer cell lines and increased G0/G1 phase distribution in the cell cycle. Furthermore, NNC 55-0396 slowed ovarian cancer formation in nude mice. Therefore the function of T-type Ca(2+) channels is important for the proliferation of human ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438841     DOI: 10.3109/07357907.2011.568565

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  15 in total

Review 1.  Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin.

Authors:  Yuan Zhang; Hua Wang; Zhiyuan Qian; Bo Feng; Xianyang Zhao; Xinghong Jiang; Jin Tao
Journal:  Pflugers Arch       Date:  2014-01-10       Impact factor: 3.657

Review 2.  T-type calcium channels blockers as new tools in cancer therapies.

Authors:  Barbara Dziegielewska; Lloyd S Gray; Jaroslaw Dziegielewski
Journal:  Pflugers Arch       Date:  2014-01-22       Impact factor: 3.657

3.  Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.

Authors:  Viktor Yarotskyy; Keith S Elmslie
Journal:  J Pharmacol Exp Ther       Date:  2011-11-16       Impact factor: 4.030

4.  N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer.

Authors:  Xiu-Hong Lv; Jia-Wei Chen; Gang Zhao; Zhen-Zhong Feng; Dao-Hua Yang; Wei-Wei Sun; Jin-Shuang Fan; Guang-Hui Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-08       Impact factor: 4.553

5.  Antihypertensive medication use and ovarian cancer survival.

Authors:  Tianyi Huang; Mary K Townsend; Robert L Dood; Anil K Sood; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2021-09-21       Impact factor: 5.482

6.  T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.

Authors:  Barbara Dziegielewska; Eli V Casarez; Wesley Z Yang; Lloyd S Gray; Jaroslaw Dziegielewski; Jill K Slack-Davis
Journal:  Mol Cancer Ther       Date:  2016-02-01       Impact factor: 6.261

7.  T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines.

Authors:  Weifeng Huang; Chunjing Lu; Yong Wu; Shou Ouyang; Yuanzhong Chen
Journal:  J Exp Clin Cancer Res       Date:  2015-05-21

8.  Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation.

Authors:  Marie-Laure Bonnefond; Bernard Lambert; Florence Giffard; Edwige Abeilard; Emilie Brotin; Marie-Hélène Louis; Mor Sény Gueye; Pascal Gauduchon; Laurent Poulain; Monique N'Diaye
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

9.  Oleuropein-Enriched Olive Leaf Extract Affects Calcium Dynamics and Impairs Viability of Malignant Mesothelioma Cells.

Authors:  Carla Marchetti; Marco Clericuzio; Barbara Borghesi; Laura Cornara; Stefania Ribulla; Fabio Gosetti; Emilio Marengo; Bruno Burlando
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-26       Impact factor: 2.629

Review 10.  Mitochondrial Ca2+ Signaling in Health, Disease and Therapy.

Authors:  Lorenzo Modesti; Alberto Danese; Veronica Angela Maria Vitto; Daniela Ramaccini; Gianluca Aguiari; Roberta Gafà; Giovanni Lanza; Carlotta Giorgi; Paolo Pinton
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.